NEW YORK (GenomeWeb) – A new study has taken the first steps in assessing whether commercially available multiplex panels can be used to deduce the cause of prosthetic joint infection, or PJI.
Published last month in the Journal of Clinical Microbiology, the study evaluated the performance of the FilmArray Blood Culture ID panel from BioMérieux subsidiary BioFire Diagnostics.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
